NEW YORK (GenomeWeb) – 10x Genomics has announced two new sequencing partnerships with Qiagen and Illumina.

Yesterday, 10x said that it is partnering with Qiagen to co-develop and co-market next-generation sequencing and single-cell biology analysis workflows and informatics solutions.

Under the terms of the agreement, Qiagen will optimize its sample technologies — including its MagAttract HMW DNA kit — for use on 10x's GemCode platform and Chromium product suite for single-cell analysis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.